Baldvinsdóttir Bryndís, Kronvall Erik, Ronne-Engström Elisabeth, Enblad Per, Klurfan Paula, Eneling Johanna, Lindvall Peter, Aineskog Helena, Friðriksson Steen, Svensson Mikael, Alpkvist Peter, Hillman Jan, Nilsson Ola G
Department of Clinical Sciences, Neurosurgery, Lund University, Lund, Sweden.
Department of Neuroscience, Section of Neurosurgery, Uppsala University, Uppsala, Sweden.
Brain Spine. 2025 Feb 20;5:104218. doi: 10.1016/j.bas.2025.104218. eCollection 2025.
Decompressive craniectomy (DC) in patients with severe aneurysmal subarachnoid hemorrhage (aSAH) can be a life-saving procedure. The aim of this nationwide prospective study was to investigate the use of DC in aSAH patients in Sweden.
To explore the risk factors and functional outcome associated with DC in patients with aSAH.
Patients treated for aSAH at all neurosurgical centers in Sweden during a 3.5-year period (2014-2018) were prospectively registered. Clinical, radiological and treatment-related factors with regard to DC were analyzed using Chi-Square and logistic regression analysis. Functional outcome was assessed by the extended Glasgow outcome scale one year after the bleeding.
During the study period, 1037 patients were treated for aSAH. Thirty-five patients (3.4%) underwent DC. At one year follow-up, 25 of these (71%) had unfavorable functional outcome. Multivariate logistic regression analysis revealed that poor clinical grade before aneurysm treatment, middle cerebral artery (MCA) aneurysm, edema on the initial computed tomography (CT), and adverse events during aneurysm occlusion were independent and significant risk factors for performing DC.
DC is relatively uncommon in aSAH patients and is related to increased risk of unfavorable outcome. However, favorable functional outcome was seen in 29% of patients with DC. Adverse events during aneurysm occlusion were significant risk factors for DC.
对于严重动脉瘤性蛛网膜下腔出血(aSAH)患者,去骨瓣减压术(DC)可能是一种挽救生命的手术。这项全国性前瞻性研究的目的是调查瑞典aSAH患者中DC的使用情况。
探讨aSAH患者中与DC相关的危险因素和功能结局。
前瞻性登记了瑞典所有神经外科中心在3.5年期间(2014 - 2018年)接受aSAH治疗的患者。使用卡方检验和逻辑回归分析对与DC相关的临床、放射学和治疗相关因素进行分析。出血一年后通过扩展格拉斯哥预后量表评估功能结局。
在研究期间,1037例患者接受了aSAH治疗。35例患者(3.4%)接受了DC。在一年随访时,其中25例(71%)功能结局不佳。多变量逻辑回归分析显示,动脉瘤治疗前临床分级差、大脑中动脉(MCA)动脉瘤、初始计算机断层扫描(CT)上的水肿以及动脉瘤闭塞期间的不良事件是进行DC的独立且显著的危险因素。
DC在aSAH患者中相对不常见,并且与不良结局风险增加相关。然而,29%接受DC的患者获得了良好的功能结局。动脉瘤闭塞期间的不良事件是DC的显著危险因素。